Table 6

Detailed analysis of the score for each ACQ question before and after an initiation/increased dose of ICS in non-eosinophilic asthmatics

ACQ questions (score ranging from 0 to 6 for each question)19Non-eosinophilic asthmatics before an initiation/increased dose of ICS (n=22)Non-eosinophilic asthmatics after an initiation/increased dose of ICS (n=22)P value
1. Frequency of nocturnal awakening due to asthma0.5±1.11.3±1.60.039
2. Severity of asthma symptoms when waking1.4±1.31.7±1.30.34
3. Limitation in activities1.6±1.41.9±1.60.16
4. Frequency of shortness of breath2.1±1.42.3±1.80.51
5. Frequency of wheeze1.5±1.32.1±1.60.13
6. Frequency of short-acting β2 agonist use0.6±0.81.3±1.50.015
7. Prebronchodilator FEV1 (% predicted)1.9±1.82.3±2.20.27
  • ACQ, Asthma Control Questionnaire; FEV1, forced expiratory volume in 1 s; ICS, inhaled corticosteroid.